Finance

Lists
214390:KRX
Kyongbo Pharmaceutical Co Ltd
5 350,00 KRW
+1,90%
(+100,00) 1D
19-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214390...
Open
5 250 KRW
High
5 420 KRW
Low
5 250 KRW
Mkt. cap
127,90 млд
Avg. vol.
24,96 миң
Volume
15,49 миң
Dividend
0,93%
Quarterly dividend
12 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
25,41
52-wk high
9 300 KRW
52-wk low
4 700 KRW
EPS
211 KRW
Shares outstanding
23,91 млн
No. of employees
588
Open
5 250 KRW
High
5 420 KRW
Low
5 250 KRW
Mkt. cap
127,90 млд
Avg. vol.
24,96 миң
Volume
15,49 миң
Dividend
0,93%
Quarterly dividend
12 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
25,41
52-wk high
9 300 KRW
52-wk low
4 700 KRW
EPS
211 KRW
Shares outstanding
23,91 млн
No. of employees
588
News stories
From web sources and news partners
About Kyongbo Pharmaceutical Co Ltd
CEOKim Tae-young
Employees588
Founded1987-ж., 31-мар.
Headquarters-
SectorPharmaceutical industry
Websitekbpharma.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
66,99 млд
71,22 млд
66,13 млд
75,22 млд
Cost of goods sold
42,39 млд
44,46 млд
38,69 млд
46,54 млд
Cost of revenue
42,39 млд
44,46 млд
38,69 млд
46,54 млд
Research and development expenses
4,46 млд
4,50 млд
4,92 млд
4,99 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,88 млд
20,67 млд
20,97 млд
21,99 млд
Operating expense
24,12 млд
26,24 млд
26,73 млд
27,75 млд
Total operating expenses
66,51 млд
70,70 млд
65,41 млд
74,29 млд
Operating income
474,48 млн
515,50 млн
712,77 млн
930,33 млн
Other non operating income
-1,10 млд
2,51 млд
-1,44 млд
3,36 млд
EBT including unusual items
3,44 млд
-995,05 млн
-741,91 млн
4,27 млд
EBT excluding unusual items
3,44 млд
-857,95 млн
-741,91 млн
4,27 млд
Income tax expense
412,26 млн
-562,40 млн
-212,24 млн
1,29 млд
Effective tax rate
11,97%
56,52%
28,61%
30,33%
Other operating expenses
194,62 млн
276,72 млн
190,08 млн
187,64 млн
Net income
3,03 млд
-432,65 млн
-529,67 млн
2,97 млд
Net profit margin
4,53%
-0,61%
-0,80%
3,95%
Earnings per share
-
-
-
-
Interest and investment income
-
41,30 млн
-
-
Interest expense
-
-4,29 млд
-
-
Net interest expenses
-
-4,25 млд
-
-
Depreciation and amortization charges
377,69 млн
385,22 млн
323,46 млн
327,67 млн
EBITDA
3,86 млд
3,95 млд
4,29 млд
4,64 млд
Gain or loss from assets sale
-6,40 млн
10,00 миң
-5,48 млн
13,90 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору